Ascendis Pharma A/S (ASND)
NASDAQ: ASND · IEX Real-Time Price · USD
124.95
+3.33 (2.74%)
Jun 21, 2024, 2:11 PM EDT - Market open

Ascendis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018 - 2012
Market Capitalization
7,0817,2626,9657,2428,7926,642
Upgrade
Market Cap Growth
-4.27%-3.82%-17.63%32.38%152.21%
Upgrade
Enterprise Value
7,3727,5346,7236,5868,0276,011
Upgrade
PE Ratio
-16.00-13.57-11.23-16.61-17.21-27.11
Upgrade
PS Ratio
19.5724.50127.93819.321036.86441.94
Upgrade
PB Ratio
-33.70-44.8624.867.218.609.90
Upgrade
P/FCF Ratio
-18.96-13.91-13.08-14.42-25.03-32.64
Upgrade
P/OCF Ratio
-19.02-13.98-13.21-15.26-26.55-33.60
Upgrade
EV/Sales Ratio
20.6125.42123.50745.12946.71399.96
Upgrade
EV/EBITDA Ratio
-23.61-16.49-12.41-15.89-20.01-25.43
Upgrade
EV/EBIT Ratio
-22.41-15.77-11.98-15.25-19.46-24.65
Upgrade
EV/FCF Ratio
-19.78-14.43-12.62-13.12-22.85-29.54
Upgrade
Debt / Equity Ratio
-2.81-4.421.930.120.110.06
Upgrade
Debt / EBITDA Ratio
-1.89-1.57-1.00-0.29-0.28-0.17
Upgrade
Debt / FCF Ratio
-1.58-1.37-1.02-0.24-0.32-0.20
Upgrade
Quick Ratio
0.490.624.457.0413.7812.61
Upgrade
Current Ratio
0.830.955.398.0314.0212.74
Upgrade
Asset Turnover
0.400.310.040.010.010.02
Upgrade
Interest Coverage
-3.13-9.76-10.44-97.17-4.19-177.75
Upgrade
Return on Equity (ROE)
511.20%-14914.70%-116.90%-45.60%-59.50%-32.90%
Upgrade
Return on Assets (ROA)
-60.30%-55.20%-46.00%-37.40%-52.20%-29.70%
Upgrade
Return on Capital (ROIC)
-83.79%-91.37%-72.80%-45.70%-35.52%-35.78%
Upgrade
Earnings Yield
-7.79%-7.37%-8.91%-6.02%-5.81%-3.69%
Upgrade
FCF Yield
-6.46%-7.19%-7.65%-6.93%-4.00%-3.06%
Upgrade
Buyback Yield / Dilution
-1.41%-0.38%-2.37%-8.21%-8.84%-13.20%
Upgrade
Total Shareholder Return
-1.41%-0.38%-2.37%-8.21%-8.84%-13.20%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).